These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 21703766)

  • 1. Reducing the future threat from (liver) fluke: realistic prospect or quixotic fantasy?
    Fairweather I
    Vet Parasitol; 2011 Aug; 180(1-2):133-43. PubMed ID: 21703766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Threat of Triclabendazole Resistance in Fasciola hepatica.
    Kelley JM; Elliott TP; Beddoe T; Anderson G; Skuce P; Spithill TW
    Trends Parasitol; 2016 Jun; 32(6):458-469. PubMed ID: 27049013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triclabendazole progress report, 2005-2009: an advancement of learning?
    Fairweather I
    J Helminthol; 2009 Jun; 83(2):139-50. PubMed ID: 19366485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fasciola hepatica: histological changes in the reproductive structures of triclabendazole (TCBZ)-sensitive and TCBZ-resistant flukes after treatment in vivo with TCBZ and the related benzimidazole derivative, Compound Alpha.
    Hanna RE; Edgar HW; McConnell S; Toner E; McConville M; Brennan GP; Devine C; Flanagan A; Halferty L; Meaney M; Shaw L; Moffett D; McCoy M; Fairweather I
    Vet Parasitol; 2010 Mar; 168(3-4):240-54. PubMed ID: 20053501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding triclabendazole resistance.
    Brennan GP; Fairweather I; Trudgett A; Hoey E; McCoy ; McConville M; Meaney M; Robinson M; McFerran N; Ryan L; Lanusse C; Mottier L; Alvarez L; Solana H; Virkel G; Brophy PM
    Exp Mol Pathol; 2007 Apr; 82(2):104-9. PubMed ID: 17398281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of fasciolosis and evaluation of drug efficacy against Fasciola hepatica in dairy cattle in the Maffra and Bairnsdale districts of Gippsland, Victoria, Australia.
    Elliott TP; Kelley JM; Rawlin G; Spithill TW
    Vet Parasitol; 2015 Apr; 209(1-2):117-24. PubMed ID: 25771931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for high genetic diversity of NAD1 and COX1 mitochondrial haplotypes among triclabendazole resistant and susceptible populations and field isolates of Fasciola hepatica (liver fluke) in Australia.
    Elliott T; Muller A; Brockwell Y; Murphy N; Grillo V; Toet HM; Anderson G; Sangster N; Spithill TW
    Vet Parasitol; 2014 Feb; 200(1-2):90-6. PubMed ID: 24360656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the comparative efficacy of a moxidectin plus triclabendazole pour-on solution against adult and immature liver fluke, Fasciola hepatica, in cattle.
    Geurden T; Bartram D; Van Brussel L; Bo L; Scott-Baird E; Rugg D
    Vet Parasitol; 2012 Oct; 189(2-4):227-32. PubMed ID: 22579500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of triclabendazole action in vivo against a triclabendazole-resistant isolate of Fasciola hepatica following its co-administration with the metabolic inhibitor, ketoconazole.
    Devine C; Brennan GP; Lanusse CE; Alvarez LI; Trudgett A; Hoey E; Fairweather I
    Vet Parasitol; 2012 Feb; 184(1):37-47. PubMed ID: 21872399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver fluke control on sheep farms in Northern Ireland: A survey of changing management practices in relation to disease prevalence and perceived triclabendazole resistance.
    McMahon C; Edgar HW; Hanna RE; Ellison SE; Flanagan AM; McCoy M; Kajugu PE; Gordon AW; Irwin D; Barley JE; Malone FE; Brennan GP; Fairweather I
    Vet Parasitol; 2016 Jan; 216():72-83. PubMed ID: 26801598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triclabendazole: new skills to unravel an old(ish) enigma.
    Fairweather I
    J Helminthol; 2005 Sep; 79(3):227-34. PubMed ID: 16153316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug resistance in liver flukes.
    Fairweather I; Brennan GP; Hanna REB; Robinson MW; Skuce PJ
    Int J Parasitol Drugs Drug Resist; 2020 Apr; 12():39-59. PubMed ID: 32179499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and economic consequences of triclabendazole resistance in Fasciola hepatica in a sheep flock in south-east Scotland.
    Sargison ND; Scott PR
    Vet Rec; 2011 Feb; 168(6):159. PubMed ID: 21493511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered drug influx/efflux and enhanced metabolic activity in triclabendazole-resistant liver flukes.
    Alvarez LI; Solana HD; Mottier ML; Virkel GL; Fairweather I; Lanusse CE
    Parasitology; 2005 Oct; 131(Pt 4):501-10. PubMed ID: 16174415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fasciola hepatica: histological demonstration of apoptosis in the reproductive organs of flukes of triclabendazole-sensitive and triclabendazole-resistant isolates, and in field-derived flukes from triclabendazole-treated hosts, using in situ hybridisation to visualise endonuclease-generated DNA strand breaks.
    Hanna RE; Forster FI; Brennan GP; Fairweather I
    Vet Parasitol; 2013 Jan; 191(3-4):240-51. PubMed ID: 23062689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fasciolicides: efficacy, actions, resistance and its management.
    Fairweather I; Boray JC
    Vet J; 1999 Sep; 158(2):81-112. PubMed ID: 10489266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased action of triclabendazole (TCBZ) in vitro against a TCBZ-resistant isolate of Fasciola hepatica following its co-incubation with the P-glycoprotein inhibitor, R(+)-verapamil.
    Savage J; Meaney M; Brennan GP; Hoey E; Trudgett A; Fairweather I
    Exp Parasitol; 2013 Nov; 135(3):642-53. PubMed ID: 24090567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of vitellogenesis and spermatogenesis by triclabendazole (TCBZ) in a TCBZ-resistant isolate of Fasciola hepatica following incubation in vitro with a P-glycoprotein inhibitor.
    Savage J; Meaney M; Brennan GP; Hoey E; Trudgett A; Fairweather I
    Parasitology; 2014 Jul; 141(8):1064-79. PubMed ID: 24889697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standardisation of a coproantigen reduction test (CRT) protocol for the diagnosis of resistance to triclabendazole in Fasciola hepatica.
    Flanagan AM; Edgar HW; Forster F; Gordon A; Hanna RE; McCoy M; Brennan GP; Fairweather I
    Vet Parasitol; 2011 Feb; 176(1):34-42. PubMed ID: 21093156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance of Fasciola hepatica against triclabendazole in cattle and sheep in The netherlands.
    Moll L; Gaasenbeek CP; Vellema P; Borgsteede FH
    Vet Parasitol; 2000 Jul; 91(1-2):153-8. PubMed ID: 10889368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.